Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;21(9):613-615.
doi: 10.1111/hiv.12900. Epub 2020 Sep 1.

Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort

Nicolò Girometti  1 , Frances Lander  1 , Alan McOwan  1 , Nneka Nwokolo  1 , Marta Boffito  1   2 , Gary Whitlock  1 ; Dean Street Collaborative group†
Collaborators, Affiliations
Free article

Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort

Nicolò Girometti et al. HIV Med. 2020 Oct.
Free article

Abstract

Objectives: Rapid antiretroviral therapy (ART) initiation is recommended in early HIV infection (EHI), even in the absence of baseline viral resistance test result. We analysed time to viral suppression according to ART regimen started in a cohort of patients diagnosed with EHI.

Methods: Clinical records of individuals consecutively diagnosed with EHI between July 2016-June 2018 were reviewed. The distribution of clinical, virological and immunological factors was compared in treatment groups using the Mann-Whitney U-test.

Results: 262 individuals (97% MSM) were diagnosed with EHI. 58% of patients agreed to start ART within 14 days of diagnosis. Tenofovir-based combinations were prescribed to all patients. DRV/b was the most commonly prescribed third agent (78%), when genotypic resistance testing was not available at time of ART choice. Switching to INSTI was encouraged once VRT became available and 27% switched from DRV/b to INSTI (mainly RAL) within 28 days from ART start. Those receiving INSTI were more likely to have a baseline viral load exceeding 1 million HIV-1 RNA copies/mL compared with those starting with DRV/b. Rapid start with INSTI regimens resulted in quicker viral suppression than when DRV/b was chosen in EHI, even when that was subsequently switched to INSTI. Retention in care following rapid ART start was achieved by all patients at 24 weeks.

Conclusions: Starting an INSTI-based ART combination was associated with quicker viral suppression than when a protease inhibitor-based combination was chosen. No differences in the achievement of viral suppression or in retention in care were observed.

Keywords: integrase inhibitors; rapid ART; seroconversion; test and treat; treatment as prevention.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Temprano ANRS. 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015; 373 (9): 808-822.
    1. Insight Start Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015; 373 (9): 795-807.
    1. Cohen MS, Chen YQ, McCauley M et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016; 375 (9): 830-839.
    1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. (accessed 14 October 2019).
    1. EACS guidelines. (2018) Available at www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.htmlwww.ea... (PDF). (accessed 14 October 2019).

MeSH terms